In-Vitro and In-Silico Evaluations of Heterocyclic-Containing Diarylpentanoids as Bcl-2 Inhibitors Against LoVo Colorectal Cancer Cells (2020)
Attributed to:
Translational development of oncolytic Newcastle Disease Virus for treatment of colorectal cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/molecules25173877
PubMed Identifier: 32858795
Publication URI: http://europepmc.org/abstract/MED/32858795
Type: Journal Article/Review
Parent Publication: Molecules
Issue: 17